for balding traders - advangen product release, page-3

Agree. If the release of a new retail product line by a company currently living off shareholder dilution is not price sensitive I don't know what is. At least the ann was released prior to open.

My thinking is that "selected hairdressers" will be able to market this product far more effectively than Cellmid lol. I shouldn't say that but "word of mouth" recommendations can start from this point.

The company said that FG5 protein inhibitors (contained in the product) will assist about 50% of users . . . presumably some more than others. I would like more specifics on this (as would the selectedhairdressers).

I wish I knew more about the science. A little knowledge just leads to more questions . . . and I am wondering whether women are (or should be) the key target of this product line. If so, this is huge becasue women do not generally lose hair due to testosterone triggers and they definitely don't like the side effects (facial & ear hair) of some other products.

Anyway todays ann is great for holders for the reason I have stated.

cheers